Clinical Trial

DOLCE: Determining the Impact of Optellum's Lung Cancer Prediction Solution

Study acronym: DOLCE
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 8, 2025 (before its estimated August 2025 completion). Its status may not reflect the trial's current state.
Summary
This study is a multi-centre prospective observational cohort study recruiting patients with 5-30mm solid and part-solid pulmonary nodules that have been detected on CT chest scans performed as part of routine practice. The aim is to determine whether physician decision making with the AI-based LCP tool, generates clinical and health-economic benefits over the current standard of care of these patients.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2022-05-20; most recent amendment 2025-04-04.
Status change: Not Yet Recruiting → Recruiting 2023-03-31
Trial Details
NCT Number NCT05389774
Lead Sponsor Nottingham University Hospitals NHS Trust
Collaborators: Optellum Ltd.
Conditions AI (Artificial Intelligence), Pulmonary Nodule, Solitary, Pulmonary Nodule, Multiple, Lung Cancer
Enrollment 2,000 participants
Start Date 2023-03-23
Primary Completion 2025-08 (estimated)
Study Completion 2025-08 (estimated)
Updated on ClinicalTrials.gov 2025-04-08